Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Product
39
155
376
Support
4
20
65
Total revenue
43
174
440
Product
20
63
133
Support
4
14
35
Total cost of revenue
24
78
168
Gross Profit
19
97
272
Research and development
36
93
167
Sales and Marketing
55
152
241
General and administrative
6
32
75
Total operating expenses
97
277
483
Loss from operations
-78
-180
-210
Other income (expense), net
0
-1
-2
Loss before provision for income taxes
-78
-182
-212
Provision for income taxes
0
1
2
Net loss
-79
-183
-214
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (31 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
193
605
Marketable securities
n/a
0
0
Accounts receivable, net of allowance
n/a
59
126
Inventory
n/a
22
21
Current portion of deferred commissions.
n/a
9
16
Prepaid expenses and other current assets
n/a
11
21
Total current assets
n/a
294
788
Property and equipment, net
n/a
40
53
Intangible assets, net
n/a
8
7
Deferred income taxes, non-current
n/a
0
1
Other long-term assets
n/a
14
23
Total assets
n/a
356
871
Liabilities and owners' equity
Accounts payable
n/a
11 11007000
38 38187000
Accrued compensation and benefits
n/a
14 13811000
33 32995000
Accrued expenses and other liabilities
n/a
6 6106000
14 14076000
Deferred revenue, current
n/a
32 32199000
95 94514000
Liability associated with stock options that were early exercised.
n/a
6 6485000
5 4760000
Total current liabilities
n/a
70 69608000
185 184532000
Deferred revenue, non-current
n/a
41 41470000
122 121690000
Deferred income taxes, non-current
n/a
0 300000
0 0
Other long-term liabilities
n/a
1 802000
1 1207000
Total liabilities
n/a
112 112180000
307 307429000
Commitments and contingencies (Note 5)
n/a
0 0
0 0
Convertible preferred stock
n/a
544 543940000
0 0
Preferred stock
n/a
0 0
0 0
Class A and Class B common stock
n/a
0 4000
0 19000
Additional paid-in capital
n/a
42 41749000
1,119 1118670000
Accumulated other comprehensive income
n/a
0 0
0 0
Accumulated deficit
n/a
-342 -341583000
-555 -555335000
Total stockholders’ (deficit) equity
n/a
-300 -299830000
563 563354000
Total liabilities, convertible preferred stock, and stockholders’ (deficit) equity
n/a
356 356290000
871 870783000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Sep 6, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (28 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Net loss
-79
-183
-214
Depreciation and amortization
4
15
32
Stock-based compensation expense
8
25
58
Contribution of common stock to Pure Good Foundation.
0
0
12
Other
0
0
-1
Accounts receivable, net
-12
-44
-67
Inventory
-5
-14
1
Deferred commissions
-7
-10
-13
Prepaid expenses and other assets
-4
-7
-9
Accounts payable
5
3
25
Increase decrease in accrued compensation and other liabilities.
7
12
25
Deferred revenue
15
57
143
Net cash used in operating activities
-67
-144
-8
Purchases of property and equipment
-12
-42
-39
Purchases of marketable securities
0
-9
0
Change in restricted cash
-3
-2
-2
Net cash used in investing activities
-15
-53
-42
Proceeds from initial public offering, net of issuance costs
0
0
459
Proceeds from issuance of convertible preferred stock, net of issuance costs
168
281
0
Net proceeds from exercise of stock options, including proceeds from repayment of promissory notes.
3
8
6
Repurchase of common stock in connection with tender offers
-7
-30
0
Payments of deferred offering costs
0
0
-4
Net cash provided by financing activities
163
258
462
Net increase in cash and cash equivalents
81
62
412
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,